StoneX Group
CMMB icon

StoneX Group’s Chemomab Therapeutics CMMB Stock Holding History

StoneX Group’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.8K Buy
+18,620
New +$38.2K ﹤0.01% 1684

Other funds holding CMMB

Kestra Private Wealth Services
Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return
SmartHarvest Portfolios
SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

StoneX Group's CMMB Position: Q3 2026 in Review

StoneX Group opened a new position in Chemomab Therapeutics (CMMB) in Q3 2026: 18,620 shares worth $29.8K. The stake represents ﹤0.01% of the portfolio and ranks #1684 among its holdings.

6 funds tracked by Wall St. Rank hold CMMB as of Q3 2026.

  • StoneX Group held 18,620 shares of Chemomab Therapeutics worth $29.8K as of Q3 2026.
  • Chemomab Therapeutics was a new StoneX Group position in Q3 2026.
  • Chemomab Therapeutics made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1684 holding.
  • 6 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.